Objective: The aim of this placebo-controlled study was to evaluate the effect of various inferior turbinate surgery techniques on Eustachian tube dysfunction-related symptoms.
4
anatomy and physiology of the ET, there is still a lack of a diagnostic "gold standard" for obstructive ET dysfunction. 4, 11 McCoul et al. have developed the Eustachian Tube Dysfunction Questionnaire (ETDQ-7), which is a validated, organ-specific tool for the assessment of symptoms in ETD. 4 Its usefulness has been shown in recent studies. 9, 12, 13 So far, it has not been used in the evaluation of the relationship between ETD and functional problems of the nose.
The aim of this placebo-controlled study was to evaluate the effect of various inferior turbinate surgery techniques, such as radiofrequency ablation (RFA), diode laser, and microdebrider-assisted inferior turbinoplasty (MAIT), on ETD-related symptoms using the ETDQ-7 as an assessment method.
MATERIALS AND METHODS
The study was carried out at Tampere University Hospital, Tampere, Finland, between February 2014 and November 2016. The institutional review board approved the study design (R13144) and all patients provided written, informed consent. A total of 76 consecutive adult patients with enlarged inferior turbinates due to persistent year-round rhinitis were enrolled in this study. The patients presented symptoms of bilateral nasal obstruction related to inferior turbinate congestion that had not responded to a three-month trial of appropriate treatment with topical corticosteroids. Patients with significant nasal septum deviation affecting the nasal valve region, internal/external valve collapse/stenosis, chronic rhinosinusitis with or without polyposis, previous nasal surgery, sinonasal tumor, Ménière's disease, previous ear surgery, severe systemic disorder, severe obesity, and malignancy were excluded.
Cone-beam computed tomography (CBCT) (Planmeca Max, Planmeca, Helsinki, Finland) was used to exclude patients with chronic rhinosinusitis from the study. Serum-specific IgE level measurements were used to identify the patients with an allergic sensitization.
Allergic sensitization was defined as a specific IgE > 0.35 for any common airborne allergen (cat, dog, horse, birch, grass, mugwort, D. pteronyssinus, and molds).
The definition of inferior turbinate enlargement was based on persistent bilateral symptoms, a finding of bilateral swelling of the inferior turbinates in nasal endoscopy, and the evident shrinking of both turbinates in a decongestion test. The nasal response to the topical vasoconstrictor 0.5% xylometazoline hydrochloride (Nasolin, Orion, Finland)
in both nasal cavities 15 minutes before obtaining the second measurement was evaluated objectively using acoustic rhinometry (Acoustic rhinometer A1, GM instruments Ltd, Kilwinning, UK). An improvement of less than 30% in anterior nasal cavity volume (V2-5 cm) -the most sensitive measure of change in mucosal swelling during decongestion 14 -in one or both nasal cavities was considered normal, and those patients were excluded from the study. The limit value of 30% was chosen according to previous literature. 15, 16, 17 Patients were consecutively randomized into active treatment groups (RFA, diode laser, MAIT) and a sham surgery group using the Minim program, which is a free MS-DOS program that randomizes patients into treatment groups by the method of minimization. The diode laser treatment was given with a diode laser (FOX Laser, A.R.C. LASER GmbH, Nuremberg, Germany). The settings were as follows: wavelength of 980nm, output power of 6 W in continuous-wave mode, and laser delivery by a 600μm fiber using "contact"
mode. Four parallel stripes were made on the mucosa by drawing the fiber from the posterior to the anterior direction along the medial edge of the inferior turbinate.
In the MAIT treatment, a 2.9 mm-diameter rotatable microdebrider tip (Medtronic Xomed, Jacksonville, FL, USA) was firmly pushed towards the turbinate bone until it pierced the mucosa of the anterior face of the inferior turbinate. Next, a submucosal pocket was dissected by tunneling the elevator tip in an anterior to posterior and superior to inferior sweeping motion. Once an adequate pocket had been created, resection of the stromal tissue was carried out by moving the blade back and forth in a sweeping motion, with the system set at 3000 rpm using suction irrigation.
In the sham surgery procedure, small nasal mucosal biopsies for histological and cilia analysis were first taken from the anterior medial portions of the inferior turbinates, causing minor bleeding. Next, the radiofrequency tissue ablation device was turned on repeatedly near the patient, but without the needle electrodes of the device touching the patient; the patient could only hear the acoustic tone of the device. During this sound deception, a suction tube and a nasal endoscope were moved lightly in both sides of the nose for a couple of minutes in order to convince the patient that they had undergone surgery.
All the patients were evaluated prior to surgery and three months subsequent to the surgery. All clinical examinations were performed by the same examiner (T.H.) who was also the operator and not blinded to the patients' groups. The patients filled the seven-item
Eustachian Tube Dysfunction Questionnaire (ETDQ-7). During the control visits, the patients filled the questionnaire before meeting the examiner. The ETDQ-7 consists of seven questions with a seven-item Likert scale, with a response of 1 indicating no problem and 7 indicating a severe problem. The total score is divided by 7 to give an overall score ranging from 1.0 to 7.0. 4 The questions comprising the ETDQ-7 are shown in Table 1 .
Tympanometry was also performed. The tympanometry curves were classified as follows:
Type A, normal Eustachian tube function; Type B, flat tympanogram, characteristic of the presence of fluid in the middle ear or eardrum perforation; and Type C, peak at very negative pressure (< -150 dPa), which may be indicative of eardrum retraction.
Tympanometric peak pressure (TPP) -that is, the peak admittance in the tympanogram and an indirect measurement of middle ear pressure -was also documented.
IBM SPSS Statistics 22.0 was used for the statistical analyses. All the non-parametric data was statistically processed using the Wilcoxon Signed Rank test. The Chi-Squared test was used in the evaluation of tympanometry curves. The effects of multiple factors were evaluated using a three-way analysis of covariance (ANCOVA).
RESULTS
Of the 76 patients enrolled in the study, four withdrew from the study before the operation took place. A total of 72 patients underwent surgery and were finally included in the study.
The patients' characteristics are described in Table 2 . Some 45% of the patients had a preoperative ETDQ-7 total score of 1.0-1.9, 33% had a score of 2.0-2.9, and 22% had a score of 3.0 or more (range 3.1-4.4).
In the active treatment groups, there were abnormal tympanometry curves in six (five type B and one type C) ears preoperatively and seven (six type B and one type C) ears postoperatively. The difference was not statistically significant. In the sham surgery group, there was an abnormal tympanometry curve in only one ear (type C) preoperatively, and there were no abnormal findings postoperatively. This difference was not significant either.
There were no significant changes in preoperative and postoperative TPP values among either the actively treated patients or the sham surgery patients (Table 3) .
The results of the Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) are shown in Table 4 . In the evaluation of all patients, RFA, MAIT, and sham surgery procedures decreased the total score significantly. When only patients with a preoperative score 2.0 or more were evaluated, all the active treatment procedures decreased the total score significantly.
A three-way ANCOVA was run on the sample of 72 patients to examine the effect of sex, allergy status, and procedure group on the ETDQ-7 score change. Age was added to the model as a continuous covariate. In the evaluation of all patients, none of the factors had a significant individual main effect on the change in ETDQ-7 total score. There were no significant differences in the change in ETDQ-7 total score between the procedure groups, nor were there significant differences in the results between the sham surgery and any of the active treatment procedures. Allergic sensitization, sex, and age had no effect on the results either. The analysis was repeated for the patients with a preoperative total score 2.0 or more, and the same results were found.
DISCUSSION
In previous studies, the relationship between ETD and sinonasal factors has been evaluated using various methods, including symptom questions, 7, 18 tympanometry, 19, 20 and the Toynbee and Valsalva tests. 21 In order to carry out a placebo-controlled study, it is suitable to use a validated questionnaire if possible. In the present study, the relationship between nasal obstruction and ETD-related symptoms was evaluated using the ETDQ-7, which is the only patient-reported outcomes tool to have undergone initial outcome studies. It is an organ-specific instrument for the assessment of symptoms. It can provide a more precise estimate of a disease burden and may yield information not readily identified by traditional clinical methods. 4 The effect of sinonasal procedures and therapies on ET function has been evaluated in a few previous studies. Low and Willatt evaluated the relationship between middle ear pressure and a deviated nasal septum. They found out that middle ear pressure ipsilateral to the obstructed nasal passage was negatively correlated to the degree of asymmetry of the patencies of the two nasal passages. Middle ear pressure improved in both ears after septal surgery. They postulated that post-nasal airflow turbulence associated with a deviated nasal septum may lead to Eustachian tube dysfunction. 19 Deron et al., in turn, found out that correction of the septal deviation improved the passive opening pressure of the Eustachian tube on the deviated side similarly to the non-deviated side. 22 In a retrospective study by Stoikes et al., symptoms of ET were found to improve or resolve in the majority of patients undergoing endoscopic sinus surgery. 18 In their randomized, prospective, placebo-controlled trial, Gluth et al. evaluated the efficacy of nasal steroid spray in treating the tympanometric signs and symptoms of ETD. They found no statistically significant difference in the normalization of abnormal tympanometric signs or in the overall poststudy symptom score between the active treatment arm and placebo. 23 In the present study, the effect of inferior turbinate surgery on ETD-related symptoms was evaluated for the first time. The symptoms were found to improve due to inferior turbinate The internal nasal valve area is the narrowest portion of the upper nasal airway, and the anterior portion of the inferior turbinate is the predominant structure in this part of the nose; therefore, it plays a major role in nasal obstruction. 2, 24 Surgical treatment of the anterior part of the inferior turbinate has been found to be effective in decreasing nasal obstruction. 25 The posterior part of the turbinate, which is anatomically located very close to ET orifice, was not operated on in the present study. The idea of this study was also to compare the efficacy of various inferior turbinate surgery techniques in the treatment of the problem. In order to make the procedures as comparable as possible we treated the same length of the turbinate with every technique. The easiest way to guarantee that was to limit the operation to the anterior part of the inferior turbinate because in some cases it can be difficult to operate the posterior part of the turbinate under local anesthesia.
In the present study, the patients' main problem was nasal obstruction. Ear symptoms
were not their major concern in the first place. The aim of this study was to examine possible ETD-related symptoms among the patients and the effect of inferior turbinate surgery on the symptoms. A recent consensus statement defining ETD agreed that to diagnose dilatory Eustachian tube dysfunction, patient-reported symptoms should go together with evidence of negative pressure in the middle ear. 26 In the present study, more than half of the patients had an ETDQ-7 score of 2.0 or more, and more than one fifth of the patients had a score of 3.0 or more, which represents the same severity of symptoms as patients found to have ETD in the study by McCoul et al. However, only less than 10% of the patients enrolled had an abnormal tympanogram (type B or C) confirming the diagnosis of ETD. A clear weakness of ETDQ-7, in turn, is that it cannot discriminate between patients with obstructive ET dysfunction and patulous ET. Therefore, it cannot be used as a sole criterion for the diagnosis of ETD. For these reasons we are not able to generalize the results of this study to ETD. We can only talk about the effect of inferior turbinate procedure on patients' symptoms suggestive of ETD.
All clinical examinations and operations were performed by the same physician, who was not blinded to the patients' groups. Unblinding of the examining physician could introduce unintentional bias by causing misinterpretation of data. However, the examination parameters used in this study were not based on the subjective evaluation of the examining physician. Parameters of tympanometry, unlike otoscopic appearance or Valsalva and Toynbee tests, are not based on the subjective evaluation of the examiner.
That is why tympanometry was chosen to be the only objective examination method in this study. However, it is sometimes very challenging to make a confirmed diagnosis of ETD based on both patient-reported symptoms and signs of negative pressure in the middle ear in the form of abnormal tympanometry curves. In mild or fluctuating cases, the patients may have symptoms suggestive of ETD but their tympanometry curves can be within normal limits.
CONCLUSION
The improvement of ETD-related symptoms due to surgery of the anterior half of the inferior turbinate was found to be equal to placebo. The findings of this study do not support the use of reduction of the anterior half of the inferior turbinate as a sole procedure intended to treat the ear symptoms assessed by the ETDQ-7 questionnaire. 
